Shareholders Sue Arena Over Weight Drug Cancer Risk
Shareholders have filed a proposed class action against Arena Pharmaceuticals Inc. alleging its executives artificially pumped up its stock value by hiding the fact that its weight loss drug caused cancer...To view the full article, register now.
Already a subscriber? Click here to view full article